Evaluation of serum resistin levels in Iraqi rheumatoid arthritis patients under biological treatment and their correlated clinical disease activity index

Objective: The current study aimed to evaluate RA patients’ serum resistin levels and to observe the relationship between disease activity and resistin. Methods: A case-control study was conducted on (100) RA Iraqi patients during treatment with bDMARDs. The first group of 50 patients received etan...

Full description

Bibliographic Details
Main Authors: Shatha Sabah Shyaa, Hanaa Naji Abdullah, Khaled Yassin Zakair
Format: Article
Language:English
Published: Pakistan Medical Association 2023-10-01
Series:Journal of the Pakistan Medical Association
Online Access:https://ojs.jpma.org.pk/index.php/public_html/article/view/10821
_version_ 1797663576873238528
author Shatha Sabah Shyaa
Hanaa Naji Abdullah
Khaled Yassin Zakair
author_facet Shatha Sabah Shyaa
Hanaa Naji Abdullah
Khaled Yassin Zakair
author_sort Shatha Sabah Shyaa
collection DOAJ
description Objective: The current study aimed to evaluate RA patients’ serum resistin levels and to observe the relationship between disease activity and resistin. Methods: A case-control study was conducted on (100) RA Iraqi patients during treatment with bDMARDs. The first group of 50 patients received etanercept, and the second group of 50 patients were on Rituximab (RTX). The control group comprised of 50 healthy individuals. ELISA was used to evaluate serum Resistin in and anti-CRP. Inflammatory markers ESR, and CRP with biochemical tests were conducted. In addition to estimating Clinical Disease Activity score I(CDAI) by the physicians; at Baghdad Teaching Hospital. Results: Levels of Resistin of RA treated with RTX were significantly higher (16.30 ± 7.38ng/ml) than in RA treated with ETN (10.61±5.85ng/ml) compared to the control group. (6.95±1.70 ng/ml). The resistin level showed a positive correlation with Anti-CCP abs which was considered to have a high positive correlation (p< 0.01) in ETN group. While this correlation was lower than the RTX group, the, correlation between resistin, and ESR was the highest in RTX group whilst no such correlation was observed in the ETN group. There was a positive correlation with CDAI of RA subgroups (moderate activity (p<0.05), and high activity (p<0.001). The logistic regression of resistin was associated with biological treatment, odds ratio was (OR=1.138, p-value= 0.014, 95% CI.1.025-1.257) during ETN, and RTX independent of CRP. Conclusion: There is an association between serum RSN and anti CRP as a result of disease activity independent of CRP. resist in levels can be used to determine disease activity to avoid disease progression and erosion. Keywords: Protein, Antibodies, Etanercept, Rituximab, Disease, Physicians
first_indexed 2024-03-11T19:16:40Z
format Article
id doaj.art-f9086ed895e64bbda6f33224b6fb352b
institution Directory Open Access Journal
issn 0030-9982
language English
last_indexed 2024-03-11T19:16:40Z
publishDate 2023-10-01
publisher Pakistan Medical Association
record_format Article
series Journal of the Pakistan Medical Association
spelling doaj.art-f9086ed895e64bbda6f33224b6fb352b2023-10-09T05:00:06ZengPakistan Medical AssociationJournal of the Pakistan Medical Association0030-99822023-10-0173910.47391/JPMA.IQ-23Evaluation of serum resistin levels in Iraqi rheumatoid arthritis patients under biological treatment and their correlated clinical disease activity indexShatha Sabah Shyaa0Hanaa Naji Abdullah1Khaled Yassin Zakair2Department of Medical Laboratory Techniques, Middle Technical University, Baghdad, IraqDepartment of Medical Laboratory Techniques, Middle Technical University, Baghdad, IraqDepartment of Medical Laboratory Techniques, Middle Technical University, Baghdad, Iraq Objective: The current study aimed to evaluate RA patients’ serum resistin levels and to observe the relationship between disease activity and resistin. Methods: A case-control study was conducted on (100) RA Iraqi patients during treatment with bDMARDs. The first group of 50 patients received etanercept, and the second group of 50 patients were on Rituximab (RTX). The control group comprised of 50 healthy individuals. ELISA was used to evaluate serum Resistin in and anti-CRP. Inflammatory markers ESR, and CRP with biochemical tests were conducted. In addition to estimating Clinical Disease Activity score I(CDAI) by the physicians; at Baghdad Teaching Hospital. Results: Levels of Resistin of RA treated with RTX were significantly higher (16.30 ± 7.38ng/ml) than in RA treated with ETN (10.61±5.85ng/ml) compared to the control group. (6.95±1.70 ng/ml). The resistin level showed a positive correlation with Anti-CCP abs which was considered to have a high positive correlation (p< 0.01) in ETN group. While this correlation was lower than the RTX group, the, correlation between resistin, and ESR was the highest in RTX group whilst no such correlation was observed in the ETN group. There was a positive correlation with CDAI of RA subgroups (moderate activity (p<0.05), and high activity (p<0.001). The logistic regression of resistin was associated with biological treatment, odds ratio was (OR=1.138, p-value= 0.014, 95% CI.1.025-1.257) during ETN, and RTX independent of CRP. Conclusion: There is an association between serum RSN and anti CRP as a result of disease activity independent of CRP. resist in levels can be used to determine disease activity to avoid disease progression and erosion. Keywords: Protein, Antibodies, Etanercept, Rituximab, Disease, Physicians https://ojs.jpma.org.pk/index.php/public_html/article/view/10821
spellingShingle Shatha Sabah Shyaa
Hanaa Naji Abdullah
Khaled Yassin Zakair
Evaluation of serum resistin levels in Iraqi rheumatoid arthritis patients under biological treatment and their correlated clinical disease activity index
Journal of the Pakistan Medical Association
title Evaluation of serum resistin levels in Iraqi rheumatoid arthritis patients under biological treatment and their correlated clinical disease activity index
title_full Evaluation of serum resistin levels in Iraqi rheumatoid arthritis patients under biological treatment and their correlated clinical disease activity index
title_fullStr Evaluation of serum resistin levels in Iraqi rheumatoid arthritis patients under biological treatment and their correlated clinical disease activity index
title_full_unstemmed Evaluation of serum resistin levels in Iraqi rheumatoid arthritis patients under biological treatment and their correlated clinical disease activity index
title_short Evaluation of serum resistin levels in Iraqi rheumatoid arthritis patients under biological treatment and their correlated clinical disease activity index
title_sort evaluation of serum resistin levels in iraqi rheumatoid arthritis patients under biological treatment and their correlated clinical disease activity index
url https://ojs.jpma.org.pk/index.php/public_html/article/view/10821
work_keys_str_mv AT shathasabahshyaa evaluationofserumresistinlevelsiniraqirheumatoidarthritispatientsunderbiologicaltreatmentandtheircorrelatedclinicaldiseaseactivityindex
AT hanaanajiabdullah evaluationofserumresistinlevelsiniraqirheumatoidarthritispatientsunderbiologicaltreatmentandtheircorrelatedclinicaldiseaseactivityindex
AT khaledyassinzakair evaluationofserumresistinlevelsiniraqirheumatoidarthritispatientsunderbiologicaltreatmentandtheircorrelatedclinicaldiseaseactivityindex